SNAPC3

Across TCGA pan-cancer cohorts, SNAPC3 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated SNAPC3 data layer compared with 21 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SNAPC3 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNAPC3 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, STAD, and OV are the cancer types where SNAPC3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.128	0.710	.001	36	view →
STAD	OS	Median	II,III,IV	0.183	0.677	.004	24	view →
OV	OS	Median	All	0.399	0.690	.025	6	view →
LIHC	DFS	Median	II,III,IV	0.044	0.427	<.001	6	view →
COAD	DFS	Median	All	0.212	0.696	.015	3	view →
UCEC	DFS	Median	All	1.000	0.636	.044	2	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

SNAPC3–HNSC (DFS)

Open the HNSC breakdown →